Hepatocyte specific ablation of ERRγ or inverse agonist mediated inhibition of ERRγ transactivation significantly reduced hepatic FGF23 production and plasma FGF23 levels in both FA-AKI and CCl4-ALI mice. This evidence concerns the gene ESRRG and acute kidney injury.